Characterization of the Golgi complex cleared of proteins in transit and examination of calcium uptake activities.
To characterize endogenous molecules and activities of the Golgi complex, proteins in transit were > 99% cleared from rat hepatocytes by using cycloheximide (CHX) treatment. The loss of proteins in transit resulted in condensation of the Golgi cisternae and stacks. Isolation of a stacked Golgi fraction is equally efficient with or without proteins in transit [control (CTL SGF1) and cycloheximide (CHX SGF1)]. Electron microscopy and morphometric analysis showed that > 90% of the elements could be positively identified as Golgi stacks or cisternae. Biochemical analysis showed that the cis-, medial-, trans-, and TGN Golgi markers were enriched over the postnuclear supernatant 200- to 400-fold with and 400- to 700-fold without proteins in transit. To provide information on a mechanism for import of calcium required at the later stages of the secretory pathway, calcium uptake into CTL SGF1 and CHX SGF1 was examined. All calcium uptake into CTL SGF1 was dependent on a thapsigargin-resistant pump not resident to the Golgi complex and a thapsigargin-sensitive pump resident to the Golgi. Experiments using CHX SGF1 showed that the thapsigargin-resistant activity was a plasma membrane calcium ATPase isoform in transit to the plasma membrane and the thapsigargin-sensitive pump was a sarcoplasmic/endoplasmic reticulum calcium ATPase isoform. In vivo both of these calcium ATPases function to maintain millimolar levels of calcium within the Golgi lumen.
Taylor
R S
RS
Department of Cellular and Structural Biology, University of Colorado School of Medicine, Denver 80262, USA.
Jones
S M
SM
Dahl
R H
RH
Nordeen
M H
MH
Howell
K E
KE
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002118:Calcium / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics*; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D002451:Cell Compartmentation; D002462:Cell Membrane / Q000201:enzymology / Q000648:ultrastructure; D003513:Cycloheximide / Q000494:pharmacology; D003627:Data Interpretation, Statistical; D004721:Endoplasmic Reticulum / Q000737:chemistry / Q000648:ultrastructure; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006056:Golgi Apparatus / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D015151:Immunoblotting; D007425:Intracellular Membranes / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D011506:Proteins / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D012519:Sarcoplasmic Reticulum / Q000201:enzymology; D014018:Tissue Distribution
D015415:Biomarkers; D004791:Enzyme Inhibitors; D011506:Proteins; D000255:Adenosine Triphosphate; D003513:Cycloheximide; D000251:Adenosine Triphosphatases; D000252:Calcium-Transporting ATPases; D002118:Calcium